Does the Medpace (MEDP) Form 4 show any insider share sales?

The Form 4 shows no open-market sales . It reports an exercise or conversion of derivative securities , where restricted stock units converted into common shares at a price of $0.00 per share , reflecting standard equity compensation rather than discretionary selling.

Medpace (MEDP) director converts restricted stock units into 29 common shares

Q: What are the terms of the restricted stock unit grant reported by Medpace (MEDP)?

On November 28, 2025, McCarthy received a grant of 113 restricted stock units . According to the disclosure, these units vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, delivering shares over time.

Q: How many Medpace (MEDP) restricted stock units vested on March 31, 2026?

On March 31, 2026, 29 restricted stock units vested and were converted into 29 shares of Medpace common stock . This vest represents one of four scheduled installments from the 113-unit grant awarded on November 28, 2025.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Medpace Holdings director Cornelius P. McCarthy III exercised restricted stock units that converted into 29 shares of common stock on March 31, 2026. The award was part of a 113-unit grant from November 28, 2025 that vests in four approximately equal installments through December 31, 2026. Following this vesting event, he directly owns 10,324 shares of common stock and 84 restricted stock units, each representing a contingent right to receive one share of Medpace common stock.

Insider Trade Summary

29 shares exercised/converted

Mixed 2 txns

Insider McCarthy Cornelius P. III

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	29	$0.00	--
Exercise	Common Stock	29	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 84 shares (Direct); Common Stock — 10,324 shares (Direct)

Footnotes (1)

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.

Key Figures

RSUs exercised: 29 units Shares acquired from RSUs: 29 shares Exercise price: $0.00 per share +4 more

7 metrics

RSUs exercised 29 units Restricted stock units vesting and converting on March 31, 2026

Shares acquired from RSUs 29 shares Common stock received from RSU conversion on March 31, 2026

Exercise price $0.00 per share Price per share for RSU conversion to common stock

Common shares held after 10,324 shares Direct Medpace common stock ownership after the transaction

RSUs remaining 84 units Restricted stock units outstanding after the March 31, 2026 vesting

Original RSU grant 113 units Restricted stock units granted on November 28, 2025

Vesting schedule 4 installments RSUs vest on March 31, June 30, September 30 and December 31, 2026

Key Terms

Restricted Stock Unit, derivative security, contingent right, vesting, +1 more

5 terms

Restricted Stock Unit financial

"Each restricted stock unit represents a contingent right to receive one share of MEDP common stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of MEDP common stock."

vesting financial

"restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise or conversion financial

"transaction_action: derivative exercise/conversion"

Form 4 Insider Transactions: What Each Field Means →

04/02/2026 - 04:49 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCarthy Cornelius P. III

(Last)

(First)

(Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI

OHIO

45227

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/31/2026		M		29	A	⁽¹⁾	10,324	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	03/31/2026		M			29	⁽²⁾	⁽²⁾	Common Stock	29	$0	84	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

2. On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Cornelius P. McCarthy III	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Medpace (MEDP) report for Cornelius P. McCarthy III?

Medpace reported that director Cornelius P. McCarthy III exercised restricted stock units into 29 shares of common stock on March 31, 2026. This was a scheduled vesting from a prior equity grant and did not involve any open-market buying or selling activity.

How many Medpace (MEDP) shares does Cornelius P. McCarthy III hold after this Form 4?

After the March 31, 2026 transaction, Cornelius P. McCarthy III directly holds 10,324 shares of Medpace common stock. He also holds 84 restricted stock units, each representing a contingent right to receive one additional share of Medpace common stock in the future.

What are the terms of the restricted stock unit grant reported by Medpace (MEDP)?

On November 28, 2025, McCarthy received a grant of 113 restricted stock units. According to the disclosure, these units vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, delivering shares over time.

How many Medpace (MEDP) restricted stock units vested on March 31, 2026?

On March 31, 2026, 29 restricted stock units vested and were converted into 29 shares of Medpace common stock. This vest represents one of four scheduled installments from the 113-unit grant awarded on November 28, 2025.